Study documentation (link to documents, only accessible with password to www.nsgo.org).
Click HERE for access.
| Study sponsor | NSGO |
| NSGO Project Manager | Dorte Nørvang NSGO, Rigshospitalet, Copenhagen Denmark. Email: Dorte.noervang@regionh.dk +45 35 33 11 |
| Study chair | Mansoor Mirza, NSGO, Rigshospitalet Copenhagen, Denmark +45 3545 3939 |
| Drug | Durvalumab and MEDI9447 |
| Phase | II |
| Randomized trial | No |
| Type | Open label |
| Total number of patients | 25 |
| Number of patients recruited | Trial not open |
| Trial status | |
| Date of first site activated | March 2018 |
| eCRF | Open Clinica test (protected information – access only with login) Open Clinica Live ( protected information – access only with login) |
| Site list | Site list – Not available. Will be added soon. |
| Protocol summary | Not available. Will be added soon. |